(Q37062876)

18 August 2017

1 reference

title

Clinical and pathologic aspects of basal-like breast cancers (English)

1 reference

18 August 2017

Oluwole Fadare

1

1 reference

PubMed ID

18212769

18 August 2017

Fattaneh A Tavassoli

series ordinal

2

1 reference

18 August 2017

1 March 2008

1 reference

Nature Clinical Practice Oncology

18 August 2017

1 reference

18 August 2017

5

1 reference

18 August 2017

149-159

1 reference

18 August 2017

3

1 reference

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

18 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

The basal phenotype of BRCA1-related breast cancer: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

21 January 2018

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Light-generated oligonucleotide arrays for rapid DNA sequence analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Quantitative monitoring of gene expression patterns with a complementary DNA microarray

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Microarray analysis and tumor classification

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

The impact of expression profiling on prognostic and predictive testing in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

A proposed histochemical and electron microscopic classification of human breast cancer according to cell of origin.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

The phenotypic spectrum of basal-like breast cancers: a critical appraisal

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

The molecular portraits of breast tumors are conserved across microarray platforms

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Concordance among gene-expression-based predictors for breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Expression profiling predicts outcome in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

A gene-expression signature as a predictor of survival in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Molecular Portraits and 70-Gene Prognosis Signature Are Preserved throughout the Metastatic Process of Breast Cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinomas: further evidence for the pathogenesis of the basal phenotype of breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Typical medullary breast carcinomas have a basal/myoepithelial phenotype.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Myoepithelial markers are expressed in at least 29% of oestrogen receptor negative invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Molecular subtypes of breast cancer and amplification of topoisomerase II alpha: predictive role in dose intensive adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Basal-like breast carcinomas: clinical outcome and response to chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Vascular endothelial growth factor expression in the basal subtype of breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Expression of luminal and basal cytokeratins in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Prognostic relevance of basal cytokeratin expression in operable breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Gene expression profiling of breast cell lines identifies potential new basal markers.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Prognostic markers in triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Metaplastic breast carcinomas are basal-like tumours

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Differences in risk factors for breast cancer molecular subtypes in a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Images in clinical medicine. Rapid progression of basal-type breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Basal-like breast cancer and the BRCA1 phenotype

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Myoepithelial differentiation in high-grade invasive ductal carcinomas with large central acellular zones

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Spectrum of breast cancer metastasis in BRCA1 mutation carriers: highly increased incidence of brain metastases.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Protein expression profiling in high-risk breast cancer patients treated with high-dose or conventional dose-dense chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitro

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Sporadic invasive breast carcinomas with medullary features display a basal-like phenotype: an immunohistochemical and gene amplification study

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Carcinoma Arising in Microglandular Adenosis: An Immunohistochemical Analysis of 20 Intraepithelial and Invasive Neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Gene expression signatures of morphologically normal breast tissue identify basal-like tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Improved breast cancer prognosis through the combination of clinical and genetic markers

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1038

7 January 2021

Identifiers

DOI

10.1038/NCPONC1038

1 reference

18 August 2017

1 reference

PubMed ID

18212769